Litcius/Paper detail

TYK2 in Immune Responses and Treatment of Psoriasis

Lin Shang, Jiali Cao, Siqi Zhao, Jingya Zhang, Yanling He

2022Journal of Inflammation Research31 citationsDOIOpen Access PDF

Abstract

Tyrosine kinase 2 (TYK2), a key part of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, plays an integral role in the differentiation and immune responses of intrinsic immune cells and regulates the mediation of cytokines. TYK2 leads to inflammatory cascade responses in the pathogenesis of immune-mediated inflammatory diseases (IMIDs), especially psoriasis. Small-molecule TYK2 inhibitors are considered to be an effective strategy for modulating psoriasis. Here, we attempt to review the pro-inflammatory mechanisms of the JAK-STAT signaling pathway, the regulatory roles of TYK2 in the pathogenesis of psoriasis, and provide updates on ongoing and recently completed trials of TYK2 inhibitors.

Topics & Concepts

Tyrosine kinase 2Janus kinasePsoriasisSTAT proteinJAK-STAT signaling pathwayImmune systemSignal transductionImmunologyPathogenesisstatBiologyMedicineTyrosine kinaseCytokineCell biologySTAT3ReceptorInternal medicinePlatelet-derived growth factor receptorGrowth factorCytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisMast cells and histamine